Guy's & St Thomas' NHS Foundation Trust
London, SE1 9RT, United Kingdom
NCT Number: NCT05372055
The purpose of this study is to better understand the impact that Indwelling Pleural Catheters have on patients with malignant pleural effusions from a psychosocial point of view.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
London, SE1 9RT, United Kingdom
After being informed about the study, all patients giving written informed consent will undergo a baseline assessment including disease and social characteristics on the day of their Indwelling Pleural Catheter (IPC) insertion. At 2 weeks and 6-8 weeks post insertion, they will be contacted via telephone for a semi-structured interview focusing on the psychosocial impact that the IPC has had on their lives. Data surrounding the medical care of the IPC will also be collected.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Semi-structured interview focusing on psychosocial impact of living with an IPC to be performed at 2 weeks and 6-8 weeks post IPC insertion
Time frame: 2 weeks
Qualitative data
Time frame: 6-8 weeks
Qualitative data
Time frame: 2 weeks and 6-8 weeks
Qualitative data
Time frame: 2 weeks and 6-8 weeks
Qualitative data
Guy's and St Thomas' NHS Foundation Trust
Other
Malignant Pleural Effusions: Evaluating the psYchosocial Impact of Indwelling Pleural Catheters on Patients (MY-IPC)
Acronym: MY-IPC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05278975
Adenoma, Lung Diseases
Bristol, United Kingdom
View Trial DetailsNCT04322136
Cancer, Malignant Pleural Effusion
Nedlands, Western Australia, Australia
View Trial DetailsNCT02122185
Adnexal Diseases, Brenner Tumor
Birmingham, Alabama, United States
View Trial DetailsNCT02649894
Malignant Pleural Effusion, Neoplasms
Huntsville, Alabama, United States
View Trial Details